Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(852/week)
Manufacturing
(421/week)
Energy
(323/week)
Technology
(827/week)
Other Manufacturing
(261/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Alligator Bioscience
Dec 17, 2019
Alligator Bioscience: First Patient Dosed With ATOR-1017 Developed for Metastasized Cancer
Nov 29, 2019
Alligator Bioscience AB Appoints Chief Operating Officer
Nov 06, 2019
Alligator Bioscience: ATOR-1017 Induces Long-Lasting Immunity - New Preclinical Data to be Presented at SITC 34th Annual Meeting
Oct 24, 2019
Alligator Bioscience AB Interim Report January-September 2019
Jul 31, 2019
Alligator Bioscience Regains Global Rights From Janssen to CD40 Agonistic Antibody, ADC-1013 (JNJ-64457107)
Jul 11, 2019
Alligator Bioscience AB (publ) Interim Report January-June 2019
Jun 18, 2019
Alligator Bioscience Submits Clinical Trial Application for ATOR-1017
May 15, 2019
Alligator Bioscience: ADC-1013 Clinical Phase I Data to be Presented at ASCO
Apr 17, 2019
The Nomination Committee's Proposal for the Annual Shareholders' Meeting in Alligator Bioscience AB (publ)
Apr 17, 2019
Alligator Bioscience AB (publ) Interim Report January-March 2019
Apr 10, 2019
Notice of Annual Shareholders' Meeting in Alligator Bioscience AB (publ)
Apr 10, 2019
Alligator Bioscience to Present New Preclinical Data on ATOR-1015 at PEGS Boston
Apr 02, 2019
Alligator Bioscience: New Preclinical Data for ATOR-1144 Demonstrate Potential for Activation of Both the Innate and the Adaptive Immune System, as well as Direct Anti-tumor Effects
Mar 22, 2019
Alligator Bioscience's Annual Report 2018 Published
Mar 18, 2019
Alligator Bioscience: New Preclinical Data Demonstrate Strong Anti-tumor Effects for the 4-1BB Antibody ATOR-1017
Mar 07, 2019
Alligator Bioscience: First Patient Dosed in Phase I study of ATOR-1015
Feb 14, 2019
Alligator Bioscience AB Year-end Report 2018
Feb 12, 2019
Alligator Bioscience to Host Conference Call to Provide Year-end Report 2018 Business Update
Jan 29, 2019
Alligator Bioscience Publishes Clinical Phase I Data for ADC-1013 in the International Journal of Cancer
Jan 07, 2019
Alligator Bioscience Launches RUBY(TM), a Novel Concept in Bispecific Antibody Formats
‹‹
Page 2
››
Latest News
Jul 10, 2025
IFF Expands Innovation Center in Singapore with New Immersive Experience Hub
Jul 10, 2025
Murata Begins World’s First Mass Production of 47μF Multilayer Ceramic Capacitor in 0402-inch Size
Jul 10, 2025
NorthWestern to Host Second Quarter 2025 Financial Results Webinar
Jul 10, 2025
Sunnova Enters into Stalking Horse Asset Purchase Agreement with Omnidian
Jul 10, 2025
Volatus Announces Non-Brokered LIFE Financing of up to $10,000,000
Jul 10, 2025
Advisory: Chevron Corporation’s 2Q 2025 Earnings Conference Call and Webcast
Jul 10, 2025
Granite Ridge Resources Schedules Second Quarter 2025 Earnings Conference Call
Jul 10, 2025
IgniteTech Launches Next Phase for Khoros, Centered on AI and Customer Leadership
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events